Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

The solution, solid state stability and kinetic investigation in degradation studies of lercanidipine: study of excipients compatibility of lercanidipine.

Parmar N, Amin S, Singla N, Kohli K.

Pharm Dev Technol. 2012 Nov-Dec;17(6):730-40. doi: 10.3109/10837450.2011.580758. Epub 2011 May 20.

PMID:
21599490
2.

The solution and solid state stability and excipient compatibility of parthenolide in feverfew.

Jin P, Madieh S, Augsburger LL.

AAPS PharmSciTech. 2007 Dec 14;8(4):E105. doi: 10.1208/pt0804105.

3.

Stability study of flutamide in solid state and in aqueous solution.

Miranda A, Caraballo I, Millán M.

Drug Dev Ind Pharm. 2002 Apr;28(4):413-22.

PMID:
12056534
4.

Influence of formulation and processing factors on stability of levothyroxine sodium pentahydrate.

Collier JW, Shah RB, Gupta A, Sayeed V, Habib MJ, Khan MA.

AAPS PharmSciTech. 2010 Jun;11(2):818-25. doi: 10.1208/s12249-010-9434-8. Epub 2010 May 8.

5.

Surface acidity and solid-state compatibility of excipients with an acid-sensitive API: case study of atorvastatin calcium.

Govindarajan R, Landis M, Hancock B, Gatlin LA, Suryanarayanan R, Shalaev EY.

AAPS PharmSciTech. 2015 Apr;16(2):354-63. doi: 10.1208/s12249-014-0231-7. Epub 2014 Oct 16.

6.

Compatibility of chewing gum excipients with the amino acid L-cysteine and stability of the active substance in directly compressed chewing gum formulation.

Kartal A, Björkqvist M, Lehto VP, Juppo AM, Marvola M, Sivén M.

J Pharm Pharmacol. 2008 Sep;60(9):1131-8. doi: 10.1211/jpp.60.9.0003.

PMID:
18718115
7.

Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations.

Stanisz B, Regulska K, Kania J, Garbacki P.

Drug Dev Ind Pharm. 2013 Jan;39(1):51-61. doi: 10.3109/03639045.2012.657644. Epub 2012 Feb 20.

PMID:
22348774
8.

Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system.

Parmar N, Singla N, Amin S, Kohli K.

Colloids Surf B Biointerfaces. 2011 Sep 1;86(2):327-38. doi: 10.1016/j.colsurfb.2011.04.016. Epub 2011 Apr 16.

PMID:
21550214
9.

Multitemperature stability and degradation characteristics of pergolide mesylate oral liquid.

Shank BR, Ofner CM 3rd.

J Pharm Pract. 2010 Dec;23(6):570-4. doi: 10.1177/0897190010375851. Epub 2010 Aug 9.

PMID:
21507864
10.
11.
12.

Stability of doripenem in vitro in representative infusion solutions and infusion bags.

Psathas PA, Kuzmission A, Ikeda K, Yasuo S.

Clin Ther. 2008 Nov;30(11):2075-87. doi: 10.1016/j.clinthera.2008.11.013.

PMID:
19108795
13.

Effect of pharmaceutical excipients on the stability of trichlormethiazide tablets under humid conditions.

Teraoka R, Matsushima Y, Sugimoto I, Inoue K, Morita SY, Kitagawa S.

Chem Pharm Bull (Tokyo). 2009 Dec;57(12):1343-7.

14.

Miniaturized approach for excipient selection during the development of oral solid dosage form.

Raijada D, Müllertz A, Cornett C, Munk T, Sonnergaard J, Rantanen J.

J Pharm Sci. 2014 Mar;103(3):900-8. doi: 10.1002/jps.23840. Epub 2014 Jan 16.

PMID:
24436033
15.

Stabilization of rasburicase and physico-chemical characterization of the resulting injectable formulation.

Bayol A, Breul T, Dupin P, Menegotto J, Aleman C, Duplaa H, Faure P, Bonnet MC, Bauer M.

Drug Dev Ind Pharm. 2004 Sep;30(8):877-89.

PMID:
15521333
16.

Drug-excipient compatibility testing using a high-throughput approach and statistical design.

Wyttenbach N, Birringer C, Alsenz J, Kuentz M.

Pharm Dev Technol. 2005;10(4):499-505.

PMID:
16370179
17.

Degradation kinetics of antagonist [Arg6, D-Trp7,9, MePhe8]-substance P [6-11] in aqueous solutions.

Reubsaet JL, Beijnen JH, Bult A, van der Houwen OA, Teeuwsen J, Koster EH, Underberg WJ.

Anal Biochem. 1995 May 20;227(2):334-41.

PMID:
7573955
18.

Solid-state stability and compatibility studies of clavulanate potassium.

Cielecka-Piontek J, Paczkowska M, Zalewski P, Lewandowska K, Barszcz B.

Pharm Dev Technol. 2015 Mar;20(2):146-52. doi: 10.3109/10837450.2013.852571. Epub 2013 Nov 13.

PMID:
24219797
19.

Stability of polymorphic forms of ranitidine hydrochloride.

Wu V, Rades T, Saville DJ.

Pharmazie. 2000 Jul;55(7):508-12.

PMID:
10944778
20.

Screening for stability and compatibility conditions of recombinant human epidermal growth factor for parenteral formulation: effect of pH, buffers, and excipients.

Santana H, González Y, Campana PT, Noda J, Amarantes O, Itri R, Beldarraín A, Páez R.

Int J Pharm. 2013 Aug 16;452(1-2):52-62. doi: 10.1016/j.ijpharm.2013.04.054. Epub 2013 Apr 25.

PMID:
23624083

Supplemental Content

Support Center